Company: PSTV
Filing Date: 2025-04-01
Form Type: PRER14A
Source: 0001140361-25-011649
Chunk: 42

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-01
Form: PRER14A
Chunk 42
---
 of Common Stock underlying unvested options to purchase shares of Common Stock held by Dr. van Es-Johansson that will vest within 60 days of March 4, 2025. Dr. van Es-Johansson is a director of Plus Therapeutics. |

| (11) | Reflects (i) 11,188 shares of Common Stock; (ii) 4,902 shares of Common Stock issuable upon the exercise of May 2024 Series A Warrants; (iii) 4,902 shares of Common Stock issuable upon the exercise of May 2024 Warrants; and (iv) 18,174 shares of Common Stock underlying unvested options to purchase shares of Common Stock held by Mr. Hawkins that will vest within 60 days of March 4, 2025. Mr. Hawkins is the Chairman of the Board of Plus Therapeutics. |

| (12) | Reflects (i) 48,921 shares of Common Stock; (ii) 12,255 shares of Common Stock issuable upon the exercise of May 2024 Series A Warrants; (iii) 12,255 shares of Common Stock issuable upon the exercise of May 2024 Warrants; and (iv) 15,502 shares of Common Stock underlying unvested options to purchase shares of Common Stock held by Mr. Petersen that will vest within 60 days of March 4, 2025. Mr. Petersen is a director of Plus Therapeutics. |

| (13) | Reflects (i) 29,327 shares of Common Stock; (ii) 4,167 shares of Common Stock issuable upon the exercise of May 2024 Series A Warrants; (iii) 4,167 shares of Common Stock issuable upon the exercise of May 2024 Warrants; and (iv) 15,502 shares of Common Stock underlying unvested options to purchase shares of Common Stock held by Dr. Lenk that will vest within 60 days of March 4, 2025. Dr. Lenk is a director of Plus Therapeutics. |

24

#### TABLE OF CONTENTS

### ADDITIONAL INFORMATION

### SUBMISSION OF STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS FOR OUR NEXT ANNUAL MEETING

#### Proposals for Inclusion in Proxy Materials
Stockholders interested in submitting a proposal for consideration at our 2025 Annual Meeting of Stockholders must do so by sending such proposal to our